نتائج البحث

C Chauvoei/ C Septicum/C novyi/ C Sordellii/ C perfringes type C Strain PC8/C perfringes type D Strain317/ C harmolyticum/M haemolytica Type A1 قائمة الأدوية تحت التسجيل / قائمة الأدوية المعروضة على لجنة التسجيل

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Arena film-coated tablets (150 mg irbesartan) Produced by Jamjoom/ KSA versus Aprovel® film-coated tablets (150 mg irbesartan) Produced by Sanofi-aventis / Germany, in healthy subjects under fasting condition. قائمة الدراسات السريرية المسجلة على الادوية

An Open label, Single Center, prospective interventional, phase II clinical trial to evaluate the Efficacy and Safety of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine(BV-AVD) combination escalation in advanced stage classical Hodgkin lymphoma patients who did not achieve interim Positron Emission Tomography (PET2) negativity (defined as Deauville score 3 or less) after 2 cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) قائمة الدراسات السريرية المسجلة على الادوية

"A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study to DemonstrateEfficacy and Safety of A4250 in Children with Progressive Familial IntrahepaticCholestasis Types 1 and 2 (PEDFIC 1)" قائمة الدراسات السريرية المسجلة على الادوية

Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Slow Repeated IV Infusions of 2 Doses of Doxorubicin Transdrug™ (DT) (20mg/m2 and 30mg/m2) to Those of Best Standard of Care (BSC) in Patients With Advanced Hepatocellular Carcinoma (HCC) After Failure or Intolerance to Sorafenib. ReLive Study. قائمة الدراسات السريرية المسجلة على الادوية

"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlledClinical Study to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729)in Pediatric Participants (ages 10 to 17 years, inclusive) with Type 2 Diabetes Mellitus" قائمة الدراسات السريرية المسجلة على الادوية

A 52-week, double-blind, randomised, multi-centre, phase III, parallel-group study in patients 12 years and older with asthma, evaluating the efficacy and safety of Symbicort (budesonide/formoterol) Turbuhaler 160/4.5 μg 'as needed' compared with Pulmicort (budesonide) Turbuhaler 200 μg twice daily plus terbutaline Turbuhaler 0.4 mg 'as needed' قائمة الدراسات السريرية المسجلة على الادوية

Desvenlafaxine Succinate New SFDA Drug Approvals

Desvenlafaxine Succinate New SFDA Drug Approvals

Recommendations for Healthcare Providers regarding the safe and effective use of Autoclave Devices التقارير الأسبوعية للمركز الوطني لبلاغات الأجهزة والمنتجات الطبية

عرض 351 - 360 من 3385